Patent · US Active

Method of mitigating long and short term detrimental effects of exposure to medical imaging ionizing radiation by administration of genistein

US9623003B1 · kind B1 · utility

0Cited by

0References

6Claims

0Family size

Assignee

Humanetics Corporation · US

Inventors

Michael D. Kaytor · Maplewood, US
John L. Zenk · Eden Prairie, US

Key dates

Filing date	Apr 4, 2013
Grant date	Apr 18, 2017
Priority date	—
Expiry date	Apr 4, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Mitigation of long and short-term detrimental effects of exposure to medical imaging ionizing radiation by administration of an effective amount of genistein in the form of a nanosuspension to someone within forty eight hours prior to and/or within twelve hours after exposure to medical imaging ionizing radiation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.